Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Little

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Exceptional Children|November 1, 1973
Early childhood education for exceptional foster children and training of foster parentsA D Quick, T L Little, A A Campbell
Journal of Analytical Toxicology|January 1, 1988
2H6-11-nor-delta-8-thc-9-COOH: a new internal standard for the analysis of THC metabolite in biological fluidsM A elSohly, D F Stanford, T L Little
American Journal of Hospital Pharmacy|April 1, 1982
Stability of methadone pain cocktailsT L Little, V M Tielke, R K Carlson
Journal of Medicinal Chemistry|May 1, 1986
Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenesM A ElSohly, P D Adawadkar, D A Benigni, et al.
Pharmacology, Biochemistry, and Behavior|November 11, 1991
Rectal bioavailability of delta-9-tetrahydrocannabinol from various estersM A Elsohly, T L Little, A Hikal, et al.
Journal of Analytical Toxicology|July 1, 1988
GC/MS analysis of phencyclidine acid metabolite in human urineM A elSohly, T L Little, J M Mitchell, et al.
Journal of Pharmaceutical Sciences|October 11, 1991
Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeysM A ElSohly, D F Stanford, E C Harland, et al.
Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.
Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Exceptional Children|November 1, 1973
Early childhood education for exceptional foster children and training of foster parentsA D Quick, T L Little, A A Campbell
Journal of Analytical Toxicology|January 1, 1988
2H6-11-nor-delta-8-thc-9-COOH: a new internal standard for the analysis of THC metabolite in biological fluidsM A elSohly, D F Stanford, T L Little
American Journal of Hospital Pharmacy|April 1, 1982
Stability of methadone pain cocktailsT L Little, V M Tielke, R K Carlson
Journal of Medicinal Chemistry|May 1, 1986
Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenesM A ElSohly, P D Adawadkar, D A Benigni, et al.
Pharmacology, Biochemistry, and Behavior|November 11, 1991
Rectal bioavailability of delta-9-tetrahydrocannabinol from various estersM A Elsohly, T L Little, A Hikal, et al.
Journal of Analytical Toxicology|July 1, 1988
GC/MS analysis of phencyclidine acid metabolite in human urineM A elSohly, T L Little, J M Mitchell, et al.
Journal of Pharmaceutical Sciences|October 11, 1991
Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeysM A ElSohly, D F Stanford, E C Harland, et al.
Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.
Journal of Medicinal Chemistry|July 21, 1998
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studiesP S Dragovich, S E Webber, R E Babine, et al.
Pageof 2